{
  "id": 3687,
  "text": "A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.Eur J Cancer 37, 1624-1628 (2001).1689.Ramm, K., Vergote, I.B., Kaern, J.& Trope, C.G.Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.Eur J Cancer 37, 1624-1628 (2001).1689.Ramm, K., Vergote, I.B., Kaern, J.& Trope, C.G.Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.\n\n<question>: ",
  "ChatGPT_response_0": "根据欧洲癌症研究与治疗组织（EORTC）进行的研究，治疗之前接受过放疗的宫颈癌患者的盆腔复发中，一种药物组合是Bleomycin-ifosfamide-cisplatinum (BIP)。这种组合药物在处理该类情况下被考虑，并展现出一定的效果。需注意在治疗过程中密切监测患者病情及药物的副作用情况。",
  "query": "在治疗妇科癌症方面，欧洲癌症研究与治疗组织(EORTC)进行的研究中，有哪些药物组合被用于治疗之前接受过放疗的宫颈癌患者的盆腔复发？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗妇科癌症方面，欧洲癌症研究与治疗组织(EORTC)进行的研究中，有哪些药物组合被用于治疗之前接受过放疗的宫颈癌患者的盆腔复发？\n\n<reference text>: A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.Eur J Cancer 37, 1624-1628 (2001).1689.Ramm, K., Vergote, I.B., Kaern, J.& Trope, C.G.Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.\n\n<reply>: ",
  "response": "根据欧洲癌症研究与治疗组织（EORTC）进行的研究，治疗之前接受过放疗的宫颈癌患者的盆腔复发中，一种药物组合是Bleomycin-ifosfamide-cisplatinum (BIP)。这种组合药物在处理该类情况下被考虑，并展现出一定的效果。需注意在治疗过程中密切监测患者病情及药物的副作用情况。"
}